Key result
Adding intracoronary vitamin C to L-NMMA and dobutamine significantly increased LV +dP/dt by 37 ± 5% compared to 25 ± 5% with dobutamine alone (P < 0.05).
Why the study?
Does the addition of vitamin C to L-NMMA and dobutamine improve the inotropic response in patients with heart failure?
Does the addition of vitamin C to L-NMMA and dobutamine improve the inotropic response in patients with heart failure?
Absolute Event Rate: 37% vs 25%
p-value: p=< 0.05
In patients with heart failure, endogenous nitric oxide opposes the positive effect of vitamin C on adrenergically stimulated contractility, as demonstrated by improved inotropic response when vitamin C is given during NO synthase inhibition.
Hypothesis-generating for NO modulation of vitamin C effects on contractility in HF; does not support practice change.
The positive effect of vitamin C on left ventricular (LV) inotropic responses to dobutamine, observed in patients with preserved LV function, is lost in heart failure (HF). We tested the hypothesis that in HF, endogenous nitric oxide (NO) opposes the positive effect of vitamin C on adrenergically stimulated contractility by examining the effects of vitamin C on dobutamine responses during NO synthase inhibition. In 11 HF patients, a micromanometer-tipped catheter was inserted into the LV and an infusion catheter was positioned in the left main coronary artery. The peak positive rate of change of LV pressure (LV +dP/dt) was measured in response to intravenous dobutamine (Dob-1). After recontrol, intracoronary N(G)-monomethyl-L-arginine (l-NMMA) was infused before reinfusion of dobutamine (L-NMMA + Dob-2). Finally, intracoronary vitamin C was infused in addition to intracoronary L-NMMA and dobutamine (L-NMMA + Dob-2 + vitamin C). Intracoronary L-NMMA alone had no effect on LV +dP/dt. After a stable inotropic response to intracoronary L-NMMA and dobutamine was established, the addition of intracoronary vitamin C resulted in a modest but significant increase in LV +dP/dt. The change in LV +dP/dt in response to dobutamine alone was 25 +/- 5%, with intracoronary L-NMMA, 27 +/- 6%, and with intracoronary L-NMMA plus vitamin C, 37 +/- 5% (P < 0.05 vs. Dob-1 and L-NMMA + Dob-2). These findings demonstrate that an interaction between endogenous NO and redox environment exists and exerts some influence on stimulated contractility in HF.
No takes yet. Share an insight, caveat, or question.
Mak et al. (2005) studied Heart failure (n=11). Intracoronary vitamin C and L-NMMA vs. Dobutamine alone and L-NMMA plus dobutamine was evaluated on Change in peak positive rate of change of LV pressure (LV +dP/dt) (p=< 0.05). Adding intracoronary vitamin C to L-NMMA and dobutamine significantly increased LV +dP/dt by 37 ± 5% compared to 25 ± 5% with dobutamine alone (P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: